Non-small Cell Lung Cancer with Alk Rearrangement

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-05-31
Clinical Trial Update: A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies [Phase 2]
A Phase 2 trial evaluating platinum-pemetrexed-atezolizumab with or without bevacizumab for stage IIIB/IV non-squamous non-small cell lung c…